Pluri (PLUR) Change in Accured Expenses (2010 - 2025)
Pluri (PLUR) reported Change in Accured Expenses of $903000.0 for Q4 2025, up 157.63% year-over-year from $350508.1 in Q4 2024, and up 320.24% quarter-over-quarter from -$410000.0 in Q3 2025.
Pluri (PLUR) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of Change in Accured Expenses data on file, last reported at $903000.0 in Q4 2025.
- Change in Accured Expenses for Q4 2025 came in at $903000.0, up 157.63% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.1 million (up 179.35% YoY), and the FY2025 annual result was $377000.0, up 231.36% from the prior year.
- Change in Accured Expenses climbed to $903000.0 in Q4 2025 per PLUR's latest filing, from -$410000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $2.3 million in Q4 2022 and troughed at -$2.1 million in Q1 2023.
- A 5-year average of -$185700.0 and a median of -$259000.0 in 2023 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2021 and 2024: Change in Accured Expenses slumped 1775.0% in 2021, then surged 381.09% in 2024.
- A 5-year view of Change in Accured Expenses shows it stood at -$1.3 million in 2021, then surged by 274.7% to $2.3 million in 2022, then slumped by 42.55% to $1.3 million in 2023, then plunged by 216.51% to -$1.6 million in 2024, then surged by 157.63% to $903000.0 in 2025.
- Business Quant data shows PLUR's Change in Accured Expenses at $903000.0 in Q4 2025, -$410000.0 in Q3 2025, and $129000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | 903,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 903,000.00 |
| Dec 31, 2025 | 903,000.00 |
| Sep 30, 2025 | -410,000.00 |
| Sep 30, 2025 | -410,000.00 |
| Jun 30, 2025 | 129,000.00 |
| Jun 30, 2025 | 129,000.00 |
| Mar 31, 2025 | 477,000.00 |
| Mar 31, 2025 | 477,000.00 |
| Dec 31, 2024 | -1.57 Mn |
| Dec 31, 2024 | -1.57 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 168,000.00 |
| Jun 30, 2024 | 168,000.00 |
| Mar 31, 2024 | -1.32 Mn |
| Mar 31, 2024 | -1.32 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Sep 30, 2023 | -476,000.00 |
| Sep 30, 2023 | -476,000.00 |